Literature DB >> 1595194

Prognostic importance of DNA flow cytometrical, histopathological and immunohistochemical parameters in neuroblastomas.

N L Carlsen1, K Ornvold, I J Christensen, H Laursen, J K Larsen.   

Abstract

In 42 tumour samples of human neuroblastoma, histological classification by differentiation (Shimada) was significantly correlated with strong positivity for neuron-specific enolase (NSE) and inversely correlated with rosette formation. Most ganglioneuroblastomas were positive for S-100 protein and reacted strongly with NSE antibody. Histological signs of high proliferative activity included intermediate or high mitosis-karyorrhexis index, necrosis and lack of calcification, which were significantly correlated with each other. Flow cytometric DNA analysis demonstrated that 88% of the tumour samples had DNA aneuploid stem lines. High S phase fraction (greater than or equal to 0.20) was significantly correlated with necrosis and lack of calcification. Univariate analysis of prognosis for 26 patients whose tumour samples were obtained before adjuvant treatment showed that five factors were significantly related to a better outcome: early stage of the disease (stages I, II, IV-S), S phase fraction less than 0.20, favourable Shimada histology, positivity for S-100 protein, and strong positivity for NSE. In multivariate analysis, only S phase fraction or stage of disease remained significantly associated with prognosis. DNA index did not correlate with prognosis in this study.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1595194     DOI: 10.1007/bf01600512

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  46 in total

1.  A comparison of four staging systems for localized and regional neuroblastoma: a report from the Childrens Cancer Study Group.

Authors:  A E Evans; G J D'Angio; H N Sather; A A de Lorimier; A Dalton; R S Ungerleider; J Z Finklestein; G D Hammond
Journal:  J Clin Oncol       Date:  1990-04       Impact factor: 44.544

2.  The neuroendocrine and neural profiles of neuroblastomas, ganglioneuroblastomas, and ganglioneuromas.

Authors:  W M Molenaar; D L Baker; D Pleasure; V M Lee; J Q Trojanowski
Journal:  Am J Pathol       Date:  1990-02       Impact factor: 4.307

3.  Chromosome abnormalities, cellular DNA content, oncogene amplification and growth pattern in agar culture of human neuroblastomas.

Authors:  N L Carlsen; B T Mortensen; P K Andersson; J K Larsen; O H Nielsen; N Tommerup
Journal:  Anticancer Res       Date:  1991 Jan-Feb       Impact factor: 2.480

4.  Neuronal and glial markers in tumours of neuroblastic origin.

Authors:  F Carlei; J M Polak; A Ceccamea; P J Marangos; D Dahl; D Cocchia; F Michetti; E Lezoche; V Speranza
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

5.  Neuroblastoma, its natural history and prognosis: a study of 487 cases.

Authors:  L M Wilson; G J Draper
Journal:  Br Med J       Date:  1974-08-03

6.  Histopathologic features of composite ganglioneuroblastoma. Immunohistochemical distinction of the stromal component is related to prognosis.

Authors:  C Aoyama; S J Qualman; M Regan; H Shimada
Journal:  Cancer       Date:  1990-01-15       Impact factor: 6.860

7.  Prognostic factor in neuroblastoma.

Authors:  A E Evans; G J D'Angio; K Propert; J Anderson; H W Hann
Journal:  Cancer       Date:  1987-06-01       Impact factor: 6.860

8.  Prognostic factors in neuroblastomas treated in Denmark from 1943 to 1980. A statistical estimate of prognosis based on 253 cases.

Authors:  N L Carlsen; I J Christensen; H Schroeder; P V Bro; G Erichsen; B Hamborg-Pedersen; K B Jensen; O H Nielsen
Journal:  Cancer       Date:  1986-12-15       Impact factor: 6.860

9.  A comparative analysis of nuclear DNA content and N-myc gene amplification in neuroblastoma.

Authors:  S R Taylor; J Locker
Journal:  Cancer       Date:  1990-03-15       Impact factor: 6.860

10.  myc gene amplification and expression in primary human neuroblastoma.

Authors:  I Slavc; R Ellenbogen; W H Jung; G F Vawter; C Kretschmar; H Grier; B R Korf
Journal:  Cancer Res       Date:  1990-03-01       Impact factor: 12.701

View more
  5 in total

1.  Effects of gamma-IFN and NGF on subpopulations in a human neuroblastoma cell line: flow cytometric and morphological analysis.

Authors:  J Ridge; D A Terle; E Dragunsky; I Levenbook
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-04       Impact factor: 2.416

2.  DNA content heterogeneity in neuroblastoma analyzed by means of image cytometry and its potential significance.

Authors:  Zsombor Melegh; Erzsébet Csernák; Erika Tóth; Zsuzsa Veleczki; Edina Magyarosy; Kálmán Nagy; Zoltán Szentirmay
Journal:  Virchows Arch       Date:  2005-04-13       Impact factor: 4.064

Review 3.  Neuroblastoma: current drug therapy recommendations as part of the total treatment approach.

Authors:  F Berthold; B Hero
Journal:  Drugs       Date:  2000-06       Impact factor: 9.546

4.  Peripheral primitive neuroectodermal tumour and extra-osseous Ewing's sarcoma; a histological, immunohistochemical and DNA flow cytometric study.

Authors:  M Brinkhuis; L C Wijnaendts; J C van der Linden; A J van Unnik; P A Voûte; J P Baak; C J Meijer
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

5.  Prognostic importance of DNA flow cytometric variables in rhabdomyosarcomas.

Authors:  L C Wijnaendts; J C van der Linden; P van Diest; A J van Unnik; J F Delemarre; P A Voûte; C J Meijer
Journal:  J Clin Pathol       Date:  1993-10       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.